Inicio › Cáncer (todos los tipos) › Tennessee › Nashville
Ensayos clínicos de Cáncer (todos los tipos) en Nashville, TN
65 estudios para Cáncer (todos los tipos) buscan participantes en centros de Nashville y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
ReclutandoFase 2/3
- SCRI Oncology Partners /ID# 276959, Nashville
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
ReclutandoFase 2
- SCRI Oncology Partners /ID# 279733, Nashville
A Study of ASP3082 in Adults With Advanced Solid Tumors
ReclutandoFase 1
- Vanderbilt University Medical Center, Nashville
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
ReclutandoFase 3
- SCRI Oncology Partners, Nashville
A Study of PHN-012 in Patients With Advanced Solid Tumors
ReclutandoFase 1
- PHN-012-001 Site, Nashville
Registry Study for Radiation Therapy Outcomes
ReclutandoEstudio observacional
- Tennessee Oncology Proton Center, Franklin · A 17 mi de distancia
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
ReclutandoEstudio observacional
- Vanderbilt University Medical Center, Nashville
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
ReclutandoFase 1
- GSK Investigational Site, Nashville
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
ReclutandoEstudio observacional
- Vanderbilt University Medical Center, Nashville
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
ReclutandoFase 2/3
- Henry-Joyce Cancer Clinic, Nashville
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
ReclutandoFase 1
- Sarah Cannon Cancer Institute, Nashville
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
ReclutandoFase 3
- Sarah Cannon Research Institute, Nashville
- United States Oncology Regulatory Affairs Corporate Office, Nashville
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
ReclutandoFase 1
- SCRI Oncology Partners, Nashville
A Study of JNJ-87890387 for Advanced Solid Tumors
ReclutandoFase 1
- Sarah Cannon Research Institute, Nashville
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
ReclutandoFase 3
- Vanderbilt University Medical Center, Nashville
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
ReclutandoFase 3
- Quetzal Site 12, Nashville
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
ReclutandoFase 3
- SCRI Oncology Partners /ID# 279779, Nashville
- Vanderbilt University Medical Center /ID# 280169, Nashville
Pan Tumor Rollover Study
ReclutandoFase 2
- Tennesse Oncology, Nashville
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
ReclutandoFase 3
- SCRI Oncology Partners ( Site 7000), Nashville
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
ReclutandoFase 2
- Tennessee Oncology - Nashville / Sarah Cannon Research Institute, Nashville
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
ReclutandoFase 1/2
- Sarah Cannon Research Institue, Nashville
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
ReclutandoFase 2/3
- Sarah Cannon Research Inst, Nashville
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
ReclutandoFase 1/2
- GSK Investigational Site, Nashville
A Phase 1/1b Study of IAM1363 in HER2 Cancers
ReclutandoFase 1
- SCRI Oncology Partners, Nashville
- Vanderbilt Ingram Cancer Center, Nashville
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
ReclutandoFase 1
- Sarah Cannon Research Center, Nashville
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
ReclutandoFase 1/2
- SCRI Oncology Partners, Nashville
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
ReclutandoFase 3
- Research Site, Nashville
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ReclutandoFase 3
- Tennessee Oncology, Nashville
- USO - US Oncology Research Network, Nashville
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
ReclutandoEstudio observacional
- Vanderbilt University, Nashville
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
ReclutandoFase 3
- Tennessee Oncology PLLC - Chattanooga, Nashville
- Tennessee Oncology, PLLC, Nashville
- Vanderbilt University Medical Center, Nashville
Project: Every Child for Younger Patients With Cancer
ReclutandoEstudio observacional
- The Children's Hospital at TriStar Centennial, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
FOG-001 in Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Sarah Cannon Research Institute, Nashville
- Vanderbilt Ingram Cancer Center, Nashville
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville), Nashville
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
ReclutandoFase 3
- Vanderbilt Breast Center at One Hundred Oaks, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
- Vanderbilt-Ingram Cancer Center at Franklin, Franklin · A 17 mi de distancia
- y 1 más
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
ReclutandoFase 1
- SCRI Oncology Partners, Nashville
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- Sara Cannon Research Institute Tennessee, Nashville
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
ReclutandoFase 1
- Vanderbilt Ingram Cancer Center /ID# 252470, Nashville
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
ReclutandoFase 2
- SCRI Oncology Partners /ID# 274522, Nashville
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- Sarah Cannon Research Institute, Nashville
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ReclutandoFase 2
- Vanderbilt University, Ingram Cancer Center, Nashville
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
ReclutandoFase 1/2
- Tennessee Oncology, Nashville
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
ReclutandoFase 1 temprana
- Vanderbilt University Medical Center, Nashville
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
ReclutandoFase 1
- GSK Investigational Site, Nashville
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
ReclutandoFase 1
- Sarah Cannon, SCRI Oncology Partners, Nashville
CT-95 in Advanced Cancers Associated With Mesothelin Expression
ReclutandoFase 1
- Context Investigational Site, Nashville
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
ReclutandoFase 1/2
- Vanderbilt University Medical Center, Nashville
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
ReclutandoFase 1
- Research Site, Nashville
Galleri® in the Medicare Population.
ReclutandoSe aceptan voluntarios sanos
- HCA Healthcare Centennial, Nashville
- HCA Healthcare Nashville, Nashville
- HCA Healthcare Brentwood, Brentwood · A 9 mi de distancia
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
ReclutandoFase 1
- GSK Investigational Site, Nashville
Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma
ReclutandoFase 1
- Vanderbilt University Medical Center, Nashville
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
ReclutandoFase 1
- Sarah Cannon Research Institute, Nashville
Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
ReclutandoFase 1 temprana
- Vanderbilt University Medical Center, Nashville
High-Resolution PET-CT Imaging for Surgical Margin Visualization
Reclutando
- Vanderbilt University Medical Center, Nashville
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
ReclutandoFase 1
- SCRI Oncology Partners, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- SCRI Oncology Partners, Nashville
Suprachoroidal Administration in Subjects With Metastases to the Choroid
ReclutandoFase 2
- Tennessee Retina, PC, Nashville
A Study of YL242 in Subjects With Advanced Solid Tumors
ReclutandoFase 1/2
- US-205, Nashville
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
ReclutandoFase 1
- Vanderbilt-Ingram Cancer Center, Nashville
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
ReclutandoFase 1
- Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Nashville
Inherited CAncer REgistry
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Vanderbilt-Ingram Cancer Center, Nashville
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Sarah Cannon Research Institute, Nashville
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
ReclutandoFase 1/2
- SCRI Oncology Partners, Nashville
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
ReclutandoFase 1/2
- Verdi Oncology Tennessee, Scri Oncology Partners, Nashville
Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up
ReclutandoEstudio observacional
- Provision CARES Proton Therapy Nashville, Franklin · A 17 mi de distancia
Más información sobre Cáncer (todos los tipos) en MedlinePlus
Ensayos de Cáncer (todos los tipos) en otras ciudades
- Houston, TX121 estudios
- New York City, NY109 estudios
- Boston, MA85 estudios
- Los Angeles, CA74 estudios
- Philadelphia, PA59 estudios
- Washington, DC58 estudios
- Durham, NC58 estudios
- Chicago, IL51 estudios
- Atlanta, GA49 estudios
- Seattle, WA49 estudios
- Arlington, VA48 estudios
- St. Louis, MO46 estudios
Otros estudios en Nashville
- Cáncer de pulmón de células no pequeñas97 estudios
- Cáncer de seno81 estudios
- Cáncer metastásico70 estudios
- Cáncer del colon y del recto69 estudios
- Cáncer de ovario49 estudios
- Cáncer de próstata43 estudios
- Cáncer de pulmón40 estudios
- Carcinoma de células escamosas de cabeza y cuello39 estudios
- Cáncer de páncreas39 estudios
- Cáncer de endometrio38 estudios
- Melanoma33 estudios
- Mieloma múltiple32 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.